Skip to content

NMES Efficacy on Patients With NBPP

Neuromuscular Electrical Stimulation (NMES) Efficacy on Patients With Neonatal Brachial Plexus Palsy (NBPP)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01999465
Enrollment
20
Registered
2013-12-03
Start date
2013-11-30
Completion date
2018-01-31
Last updated
2018-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Brachial Plexus Palsy

Keywords

Brachial plexus injury, Brachial plexus palsy, Neonate

Brief summary

Neonatal Brachial Plexus Palsy (NBPP), characterized by weakness and sensory loss in the affected arm, results from damage in the prenatal period to the nerves extending from the spine to the arm. Proper stretching and exercise of the joints and affected arm from the time of diagnosis can greatly assist in the development of healthy movement of the limb. Additionally, neuromuscular electrical stimulation has been shown to be an effective treatment in other neural disorders and therefore its effectiveness in NBPP is worth studying. In the case of NBPP patients, the loss in normal arm function can be observed very early. Young patients will often neglect using the affected arm or modify motions to avoid the use of the biceps muscle, specifically in hand to mouth actions such as gripping a bottle or placing toys or other objects in the mouth. A goal of this study is to test the effectiveness of NMES on improving the biceps muscle Medical Research Council (MRC) strength and active range of motion (AROM). The subjects of this study are newborns between the ages of 3-9 months who are already a part of the University of Michigan Brachial Plexus program. Parents of the children will be trained to perform the neuromuscular electrical stimulation therapy at home using the EMPI Continuum unit for 30 minutes each day and monthly follow up appointments will be performed be the research occupational therapists throughout three month study period. Parents of the participants will complete a questionnaire before and during the study period to help analyze for confounders and gather data regarding parent compliance and NMES effectiveness. To detect the effectiveness of NMES, two cohort groups using standard units and sham units will be recruited and compare with data analysis. The investigators predict that the NMES will effectively improve the ability of the neonate to increase use of the affected arm, specifically in muscle strength biceps MRC score and AROM.

Detailed description

The purpose of this study is to investigate whether the use of Neuromuscular Electrical Stimulation (NMES), via the Empi® Continuum unit, will improve the ability with which children with Neonatal Brachial Plexus Palsy (NBPP) are able to use their biceps muscle in activities of daily living. We will examine the British Medical Research Council (MRC) muscle strength and participants' ability to perform active range of motion (AROM) movements. Patients will be divided into two groups with one group receiving NMES and the other receiving sham NMES. We plan to analyze the effects of this one treatment intervention of NMES to determine if the device improves the function of the biceps muscle strength and motion.

Interventions

DEVICEStandard NMES device

Blinded parents will follow the NMES parent instructions and place the NMES on the biceps muscle of their child for 30 minutes every day for three months. * Rate(35 Hz) * Width (300 us) * Ch1 Ramp+ (2 seconds) * On Time 1 (10 seconds) * Ch1 Ramp - (2 seconds)

DEVICESham NMES device

Blinded parents will follow the NMES parent instructions and place the NMES on the biceps muscle of their child for 30 minutes every day for three months. * Rate(35 Hz) * Width (48 us) * Ch1 Ramp+ (0 seconds) * On Time 1 (0 seconds) * Ch1 Ramp - (0 seconds)

Sponsors

Spring Arbor University
CollaboratorUNKNOWN
University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Months to 9 Months
Healthy volunteers
No

Inclusion criteria

* Children ages 3-9 months at time of enrollment * NBPP patients who receive care from University Of Michigan Brachial Plexus Palsy clinic * All gender/race/financial backgrounds * active range of motion (AROM) elbow flexion \<150° * All Narakas grades * British Medical Research Council (MRC) grade 2- or 4 for biceps brachii

Exclusion criteria

* Brachial Plexus patients require needing surgical repair * Patients with any existing secondary medical conditions * Patients with elbow contracture greater than 5° * British Medical Research Council (MRC) grade 5 for biceps brachii * active range of motion (AROM) elbow flexion =150° * Non-English speaking families * Children already using NMES unit

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Upper Extremity Muscle StrengthBaseline to 3-month.One of the two-blinded occupational therapists will conduct the evaluation at enrollment and 3-month follow-up clinic visit. In this study, we will evaluate the biceps strength using the British Medical Research Council (MRC) grading system. The British Medical Research Council (MRC) grading system for muscle strength is based on a scale from 0 (minimum score, not testable), 1, 2, 3, 4, to 5 (maximum score, normal strength); higher score means better outcome. British Medical Research Council (MRC) grade 2 or higher is functional in terms of muscle power. In current study, we will examine the change of biceps British Medical Research Council (MRC) grade from baseline to 3-month.
Change From Baseline in Upper Extremity Range of MotionBaseline to 3-month.One of the two-blinded occupational therapists will assess the active range of motion (AROM) of elbow flexion using goniometer at enrollment and 3-month follow-up clinic visit. The minimum degree is 0 and the maximum degree is 150; the higher degree means better outcome. We will then examine the change of elbow flexion active range of motion (AROM) from baseline to 3-month.

Other

MeasureTime frameDescription
Change From Baseline in Spontaneous Hand-to-Mouth MovementBaseline to 3-month.Study coordinators will conduct one-minute video recording with patient in supported sitting position in a chair or seated on parents lap at initial and monthly clinic visits. A toy, pacifier, or bottle will be provided to trigger patient's spontaneous hand-to-mouth movement. The frequency of hand to mouth motion will be recorded and separated out as to the positioning of the elbow. We are evaluating the motion to determine if the motion of the elbow flexion is against gravity, (the arm held at the side of the body or in an adducted position) or in gravity-eliminated position, (the arm held away from the body or in an abducted position). We are looking at the strength of the biceps in its ability to lift the arm against gravity during functional hand to mouth activities. The NMES unit will not be in use during the videotaping process; we are looking at the spontaneous movement of the extremity.
Change From Baseline in Participant's Current TherapyBaseline to 3-month.Parents will complete a survey asking participant's current therapy program, including therapy type, setting, frequency, duration, other treatment activities, splint usage, home range of motion exercise program and its frequency and duration at initial and monthly follow-up visits. The purpose of this survey is to help us understand whether there are potential confounders that could affect the study result.

Countries

United States

Participant flow

Participants by arm

ArmCount
Standard NMES Cohort
Patients who will apply standard NMES device. Standard NMES device: Blinded parents will follow the NMES parent instructions and place the NMES on the biceps muscle of their child for 30 minutes every day for three months. * Rate(35 Hz) * Width (300 us) * Ch1 Ramp+ (2 seconds) * On Time 1 (10 seconds) * Ch1 Ramp - (2 seconds)
10
Sham NMES Cohort
Patients who will apply sham NMES device. Sham NMES device: Blinded parents will follow the NMES parent instructions and place the NMES on the biceps muscle of their child for 30 minutes every day for three months. * Rate(35 Hz) * Width (48 us) * Ch1 Ramp+ (0 seconds) * On Time 1 (0 seconds) * Ch1 Ramp - (0 seconds)
7
Total17

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up02
Overall StudyProtocol Violation01

Baseline characteristics

CharacteristicSham NMES CohortStandard NMES CohortTotal
Age, Continuous4 months
STANDARD_DEVIATION 1
4 months
STANDARD_DEVIATION 2
4 months
STANDARD_DEVIATION 1
Narakas
Narakas I-II
5 Participants8 Participants13 Participants
Narakas
Narakas III-IV
2 Participants2 Participants4 Participants
NBPP-involved side
Left
2 Participants5 Participants7 Participants
NBPP-involved side
Right
5 Participants5 Participants10 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
2 Participants0 Participants2 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
5 Participants9 Participants14 Participants
Region of Enrollment
United States
7 participants10 participants17 participants
Sex: Female, Male
Female
6 Participants6 Participants12 Participants
Sex: Female, Male
Male
1 Participants4 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 7
other
Total, other adverse events
0 / 100 / 7
serious
Total, serious adverse events
0 / 100 / 7

Outcome results

Primary

Change From Baseline in Upper Extremity Muscle Strength

One of the two-blinded occupational therapists will conduct the evaluation at enrollment and 3-month follow-up clinic visit. In this study, we will evaluate the biceps strength using the British Medical Research Council (MRC) grading system. The British Medical Research Council (MRC) grading system for muscle strength is based on a scale from 0 (minimum score, not testable), 1, 2, 3, 4, to 5 (maximum score, normal strength); higher score means better outcome. British Medical Research Council (MRC) grade 2 or higher is functional in terms of muscle power. In current study, we will examine the change of biceps British Medical Research Council (MRC) grade from baseline to 3-month.

Time frame: Baseline to 3-month.

Population: One in the Standard NMES cohort was lost of follow-up and two in the sham cohort were lost of follow-up at 3 months.

ArmMeasureValue (MEDIAN)
Standard NMES CohortChange From Baseline in Upper Extremity Muscle Strength1 score on a scale
Sham NMES CohortChange From Baseline in Upper Extremity Muscle Strength1 score on a scale
p-value: 0.4Wilcoxon (Mann-Whitney)
Primary

Change From Baseline in Upper Extremity Range of Motion

One of the two-blinded occupational therapists will assess the active range of motion (AROM) of elbow flexion using goniometer at enrollment and 3-month follow-up clinic visit. The minimum degree is 0 and the maximum degree is 150; the higher degree means better outcome. We will then examine the change of elbow flexion active range of motion (AROM) from baseline to 3-month.

Time frame: Baseline to 3-month.

Population: One in the Standard NMES cohort was lost of follow-up and two in the sham cohort were lost of follow-up at 3 months.

ArmMeasureValue (MEAN)Dispersion
Standard NMES CohortChange From Baseline in Upper Extremity Range of Motion55 degreeStandard Deviation 38
Sham NMES CohortChange From Baseline in Upper Extremity Range of Motion29 degreeStandard Deviation 25
p-value: 0.2t-test, 2 sided
Other Pre-specified

Change From Baseline in Participant's Current Therapy

Parents will complete a survey asking participant's current therapy program, including therapy type, setting, frequency, duration, other treatment activities, splint usage, home range of motion exercise program and its frequency and duration at initial and monthly follow-up visits. The purpose of this survey is to help us understand whether there are potential confounders that could affect the study result.

Time frame: Baseline to 3-month.

Other Pre-specified

Change From Baseline in Spontaneous Hand-to-Mouth Movement

Study coordinators will conduct one-minute video recording with patient in supported sitting position in a chair or seated on parents lap at initial and monthly clinic visits. A toy, pacifier, or bottle will be provided to trigger patient's spontaneous hand-to-mouth movement. The frequency of hand to mouth motion will be recorded and separated out as to the positioning of the elbow. We are evaluating the motion to determine if the motion of the elbow flexion is against gravity, (the arm held at the side of the body or in an adducted position) or in gravity-eliminated position, (the arm held away from the body or in an abducted position). We are looking at the strength of the biceps in its ability to lift the arm against gravity during functional hand to mouth activities. The NMES unit will not be in use during the videotaping process; we are looking at the spontaneous movement of the extremity.

Time frame: Baseline to 3-month.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026